Arquivamento - Art. 36 §1° da LPI
#11.2
03/26/2024
RPI 2777
Back to search
Application data
Number
122023013646Type
Utility Model
Filing
06/26/2015
Publication
-
PCT
EP2015064613 Progress at the INPI
- Filing06/26/15
- Publication
- Abandoned
- Allowance
- Grant
- In force
The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 03/26/2024. We update with every new RPI gazette, published weekly.
Applicants and inventors
Applicants
NOGRA PHARMA LIMITED
IE
Inventors
No inventors listed.
Technical data
IPC Classification
No IPC classification.
Prosecution history
Publications in the Brazilian Industrial Property Gazette (RPI).
Exigência - art. 36 da LPI
#6.1
11/07/2023
RPI 2757
Notificação de pedido dividido
#2.4
08/15/2023
RPI 2745
Requerimento de pedido de patente
#2.10
Número de Protocolo '870230059326' em 07/07/2023 11:10 (WB)
07/18/2023
RPI 2741
Related
From the same holder
112026015224112025020511AGENTES ANTISSENSO DE IL-34 E MÉTODOS DE USO DOS MESMOSCOMPOSIÇÕES DE OLIGONUCLEOTÍDEOS ANTISSENTIDO SMAD7 (ASO) E MÉTODOS DE USAR AS MESMASAGENTES ANTISSENSO IL-34 E MÉTODOS DE USAR OS MESMOSOLIGONUCLEOTÍDEO ANTI-SENSO DE PROTEÍNA DE RETARDO MENTAL DO X FRÁGIL (FMRP), SEUS USOS E COMPOSIÇÃO FARMACEUTICAMENTE ACEITÁVELPROCESSOS PARA PREPARAR COMPOSTOS CAPAZES DE MODULAR A ATIVIDADE DOS RECEPTORES PPARs, DITOS COMPOSTOS E USO TERAPÊUTICO DOS MESMOSOLIGONUCLEOTÍDEOS ANTISSENSO CONTRA IL-34 E MÉTODOS DE USO DOS MESMOS
Patent monitoring
Track this patent in real time.
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.